Live Breaking News & Updates on Psychedelic Effects

Stay updated with breaking news from Psychedelic effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Microdosing Psychedelics Could Revolutionize Mental Health Treatment

Microdosing Psychedelics Could Revolutionize Mental Health Treatment
discovermagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from discovermagazine.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Joey Rootman , University Of British Columbia , Does Microdosing Impact , Psychedelic Effects ,

Indiana Senate committee passes medical psilocybin research bill

An Indiana Senate bill seeking funding for research into medical applications of psilocybin was passed unanimously by the Senate Committee on Health and Provider Services on Wednesday. Senate Bill 139 would create a therapeutic psilocybin research fund controlled by the Indiana Department of Health, which would provide financial assistance to Indiana research institutions for studying the . ....

United States , Johns Hopkins , Brandon Weiss , Richard Feldman , Ed Charbonneau , Gavin Newsom , Behavioral Health , Senate Appropriations Committee , Provider Services On , Indiana State Health , Senate Committee On Health , York University , Public Health , Drug Administration , Indiana Senate , Indiana Department Of Health , Human Services , Senate Committee , Provider Services , Indiana Department , Controlled Substances , New York University , Statehouse Democrats , Magic Mushrooms , Medical Marijuana , Indiana Senate ,

FDA Warns That a Lot of "Ketamine Therapy" Seems to Just Be Partying

Shocking news: all that "ketamine therapy" that your buddy has been doing might really just be partying, actually. Ketamine, a dissociative anesthetic known for its psychedelic effects, has had a big year. Thanks in large part to its celebrity fans — a list that notably includes Elon Musk, ketamine's number one billionaire devotee — the […] ....

New York , United States , San Francisco , Elon Musk , Peter Koshland , Drug Administration , New York Times , Wild West , Controlled Substances Act , Some Guy , Ketamine Therapy , Dissociative Anesthetic , Psychedelic Effects , Psychiatric Conditions ,

Treasury Secretary Janet Yellen Says She Ate Psychedelic Mushrooms During China Visit: 'I Learned That Later'

Yellen told CNN that while dining out on her trip, she tried a "delicious" mushroom dish that someone ordered for the table — only to find out that the mushrooms had "hallucinogenic properties" ....

United States , Janet Yellen , Barack Obama , Erin Burnett , Bill Clinton , Yi Zuo Wang , Federal Reserve , Council Of Economic Advisers , Front Monday , Economic Advisers , Psychedelic Mushrooms , Erin Burnett , Hallucinogenic Properties , Mushroom Dish , Treasury Secretary , I Zuo Yi Wang , Psychedelic Effects ,

Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study. AGN Neuro is the world’s first company to investigate DMT for the tre ....

British Columbia , United Kingdom , City Of , Christopherj Moreau , Edmundj Safra , David Nutt , Rick Strassman , Algernon Pharmaceuticals , Algernon Pharmaceuticals Inc , Constraint Induced Movement Therapy , Centre For Human Drug Research , Imperial College London , Company Phase , Algernon Neuroscience , Spirit Molecule , Psychedelic Handbook , Human Drug Research , Brain Derived Neurotrophic Factor , Constraint Induced Movement , Clinical Trial Design , Psychedelic Effects , Gn Neuro , Algernon Pharmaceuticals Inc , Pre Clinical Studies , Algernon Neuroscience , Phase 2 Study ,